caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1790858413

Thomas EngMD

NeurologyCorona, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
578
Unique beneficiaries
—
Total services
876
Distinct HCPCS
7
Medicare payment
$84K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,670 Neurology providers in CA — above median (cohort median 581).
REFERRAL NETWORK

Where Thomas Eng's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 25 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
UHS-CORONA INC149336
Unilab Corporation
Clinical Laboratory · West Hills, CA
89200
Isaac Tsai
Internal Medicine · Corona, CA
59124
Bruce Omiya
Diagnostic Radiology · Anaheim, CA
5197
Michael Chan
Diagnostic Radiology · San Diego, CA
4895
L R Moscoso
Cardiology · Corona, CA
4593
Michael Molinari
Gastroenterology · Corona, CA
44109
John Kirby
Diagnostic Radiology · Anaheim, CA
41103
Darice Liu
Interventional Radiology · Orange, CA
4163
Gilbert Plasencia
Cardiology · Corona, CA
4062
KEATING, RUSSELL2844
Roger Tsutsumi
Podiatry · Riverside, CA
2049
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
2,608
Beneficiaries
—
Total drug cost
$295K
Distinct drugs
44
Brand share
22.6%
Top prescribed drugs
Carbidopa/Levodopa233 claims
Levetiracetam217 claims
Ropinirole Hcl213 claims
Donepezil Hcl211 claims
Memantine Hcl190 claims
QUALITY · MIPS · 2024
Final MIPS score
24.3
Quality
0.0
Cost
80.9
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-6.09%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$949
Payment records
40
By payment type
Food and Beverage$949